Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group
Wien, Wien Doing business as Abcsg
- UEI
- X182EYK34L47
- CAGE
- 6807N
- Primary NAICS
- 813212 Voluntary Health Organizations
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- Nußdorfer Pl. 8, 1190 Wien, Austria
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prospectively randomized, placebo-controlled phase 3 study to determine the effect of denosumab on breast cancer… | Defense Health Agency | $5,232,648 |
Quick answers
Is Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group registered in SAM.gov?
Yes. Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group's SAM.gov registration is active through September 25, 2027.
What is Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group's most recent federal award?
Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group's most recent federal grant award is Prospectively randomized, placebo-controlled phase 3 study to determine the effect of denosumab on breast cancer… (W81XWH1910783), from Defense Health Agency, on September 15, 2019.
On GovTribe
See Verein ZUR Praevention UND Therapie Boesartiger Erkrankungen, Austrian Breast And Colorectal Cancer Study Group's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors